AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Galectin TherapeuticsAffimedNeptune Wellness SolutionsTheratechnologiesOASMIA PHARMACE/ADR
SymbolNASDAQ:GALTNASDAQ:AFMDNASDAQ:NEPTNASDAQ:THTXNASDAQ:OASM
Price Information
Current Price$2.90$3.26$2.99$1.74$1.55
52 Week RangeBuyBuyBuyBuyN/A
Beat the Market™ Rank
Overall Score2.01.61.11.30.5
Analysis Score3.53.52.33.50.0
Community Score2.72.92.62.42.5
Dividend Score0.00.00.00.00.0
Ownership Score4.01.00.00.00.0
Earnings & Valuation Score0.00.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$6.50$10.00$3.75$8.40N/A
% Upside from Price Target124.14% upside206.75% upside25.42% upside382.76% upsideN/A
Trade Information
Market Cap$164.25 million$258.45 million$283.28 million$134.70 million$116.20 million
Beta2.52.772.721.440.96
Average Volume256,4981,375,5291,291,09084,96924,780
Sales & Book Value
Annual RevenueN/A$23.96 million$18.39 million$63.22 million$220,000.00
Price / SalesN/A10.3715.462.12528.20
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.76 per share$0.57 per share$0.66 per share$0.32 per share$0.63 per share
Price / BookN/A5.724.535.442.46
Profitability
Net Income$-13,290,000.00$-36,250,000.00$-17,670,000.00$-12,500,000.00$-18,950,000.00
EPS($0.39)($0.56)($0.14)($0.14)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/A46.57N/A29.00
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-149.51%-132.09%-24.77%-8,633.64%
Return on Equity (ROE)-32.09%-93.90%-39.22%-59.18%-43.94%
Return on Assets (ROA)-29.49%-31.47%-26.36%-14.15%-28.92%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.01%0.01%2.83%N/A
Current Ratio33.35%3.01%2.30%2.18%0.80%
Quick Ratio33.35%3.00%1.70%1.53%0.73%
Ownership Information
Institutional Ownership Percentage18.40%50.88%16.85%6.96%0.11%
Insider Ownership Percentage40.70%N/AN/AN/AN/A
Miscellaneous
Employees68,406583257
Shares Outstanding57.03 million76.24 million95.06 million76.97 million74.97 million
Next Earnings Date8/14/2020 (Estimated)6/3/2020 (Estimated)6/10/2020 (Estimated)7/9/2020 (Estimated)N/A
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.